SoftMedx Healthcare Limited has announced a further extension to the long stop date of its restructuring agreement, now set for 31 December 2025. This decision comes after discussions with the Investor, acknowledging the additional time needed to meet the Resumption Conditions mandated by the SFC and the Stock Exchange. The original deadline was 30 June 2025. Conditions (d), (e), (f), and (g) of the agreement remain unfulfilled, but both parties are committed to completing the restructuring. Trading in the company's shares remains suspended, and stakeholders are advised to exercise caution.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.